checkAd

     140  0 Kommentare Bioasis Technologies Inc. Confirms TSXV Approval of Warrant Extension and Repricing - Seite 2

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Bioasis Technologies Inc. Confirms TSXV Approval of Warrant Extension and Repricing - Seite 2 NEW HAVEN, Conn., March 24, 2021 (GLOBE NEWSWIRE) - BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF;), (“Bioasis” or the “Company”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3  platform technology …